Skip to main content

Table 1 Summary and characteristics of NP management guidelines included in the study

From: Clinical practice guidelines for the management of neuropathic pain: a systematic review

Guideline name Country or region Release time Developed methods Institute Update Clinical problem Funding
EFNS guidelines on neuropathic pain assessment European 2004 Evidence-based approach EFNS (European Federation of Neurological Societies) 1 (2009) assessment EFNS
EFNS guidelines on pharmacological treatment of neuropathic pain European 2006 Evidence-based approach EFNS 1 (2010) pharmacological treatment EFNS
EFNS guidelines on neurostimulation therapy for neuropathic pain European 2007 Evidence-based approach EFNS 0 neurostimulation therapy EFNS
EFNS guidelines on neuropathic pain assessment:revised 2009 European 2009 Evidence-based approach EFNS 0 assessment EFNS
EFNS guidelines on pharmacological treatment of neuropathic pain: 2010 revision European 2010 Evidence-based approach EFNS 0 pharmacological treatment EFNS
Pharmacological management of chronic neuropathic pain - Consensus statement and guidelines from the canadian pain society Canada 2007 Evidence-based approach and Consensus statement CPS 1 (2014) pharmacological treatment Pfizer Canada
Evidence-based guideline for neuropathic pain interventional treatments: spinal cord stimulation, intravenous infusions, epidural injections and nerve blocks Canada 2012 Evidence-based approach CPS 0 Interventional treatments: spinal cord stimulation, intravenous infusions, epidural injections and nerve blocks CPS
Pharmacological management of chronic neuropathic pain: Revised Consensus statement and guidelines from the canadian pain society Canada 2014 Evidence-based approach and Consensus statement CPS   pharmacological treatment CPS
Pharmacologic management of neuropathic pain: Evidence-based recommendations International 2007 Evidence-based approach NeuPSIG 0 pharmacological treatment IASP NeuPSIG
NeuPSIG guidelines on neuropathic pain assessment International 2011 Evidence-based approach NeuPSIG 0 assessment IASP NeuPSIG
Interventional management of neuropathic pain: NeuPSIG recommendations International 2013 Evidence-based approach NeuPSIG 0 Interventional treatments IASP NeuPSIG
Pharmacological management of neuropathic pain in non-specialist settings: summary of NICE guidance United Kindom 2010 Evidence-based approach NICE 1 (2013) pharmacological treatment NICE
Neuropathic pain – pharmacological management: The pharmacological management of neuropathic pain in adults in non-specialist settings United Kindom 2013 Evidence-based approach NICE 0 pharmacological treatment NICE
Clinical practice guidelines for management of neuropathic pain: Expert panel recommendations for South Africa South Africa 2012 Consensus statement painsa (Pain South Africa); NASA (Neurological Association of South Africa); PIRA (Pain Interventions and Regional Anaesthesia); SASA (South African Society of Anaesthesiologists); SASCA (South African Spinal Cord Association) 1 (2013) neuropathic management Pfize
Guidelines for the diagnosis and management of neuropathic pain: Consensus of a group of latin american experts Latin America 2009 Consensus statement FEDELAT (Latin American Federation of Chapters of the International Association for the Study of Pain) 0 neuropathic management not mention
Guidelines for the pharmacological treatment of peripheral neuropathic pain: Expert panel recommendations for the middle east region Middle East 2010 Consensus statement A multidisciplinary panel of Middle East and international experts 0 pharmacological treatment Pfizer Inc
  1. EFNS european federation of neurological societies, CPS canadian pain society, NeuPSIG neuropathic pain special interest group, NICE national institute for health and clinical excellence